Clinical Trial of Green Tea Catechins in Men on Active Surveillance
Status:
Recruiting
Trial end date:
2024-04-15
Target enrollment:
Participant gender:
Summary
This randomized double-blinded Phase II clinical trial will evaluate the bioavailability,
safety, effectiveness and validate the mechanism by which a standardized formulation of whole
Green Tea Catechin, (Sunphenon® 90D) containing 405 mgs vs. Placebo, administered for 24
months in a cohort of men with low to intermediate grade prostate managed on active
surveillance
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute